Truist Financial Corp Gilead Sciences, Inc. Transaction History

Truist Financial Corp

  • $62.9 Billion
  • Q3 2024

A detailed history of Truist Financial Corp transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Truist Financial Corp holds 387,110 shares of GILD stock, worth $34.8 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
387,110
Previous 406,901 4.86%
Holding current value
$34.8 Million
Previous $27.9 Million 16.23%
% of portfolio
0.05%
Previous 0.04%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$66.59 - $83.99 $1.32 Million - $1.66 Million
-19,791 Reduced 4.86%
387,110 $32.4 Million
Q2 2024

Aug 20, 2024
SELL
$63.15 - $72.88 $2.5 Million - $2.88 Million
-39,572 Reduced 8.86%
406,901 $27.9 Million
Q1 2024

May 10, 2024
SELL
$71.58 - $87.29 $3.37 Million - $4.11 Million
-47,044 Reduced 9.53%
446,473 $32.7 Million
Q4 2023

Feb 02, 2024
SELL
$73.27 - $83.09 $5.86 Million - $6.64 Million
-79,928 Reduced 13.94%
493,517 $40 Million
Q3 2023

Nov 14, 2023
BUY
$73.94 - $80.67 $583,386 - $636,486
7,890 Added 1.4%
573,445 $43 Million
Q2 2023

Aug 01, 2023
SELL
$76.01 - $86.7 $7.24 Million - $8.26 Million
-95,273 Reduced 14.42%
565,555 $43.6 Million
Q1 2023

May 05, 2023
SELL
$77.31 - $88.08 $12.6 Million - $14.3 Million
-162,731 Reduced 19.76%
660,828 $54.8 Million
Q4 2022

Feb 17, 2023
SELL
$62.32 - $89.47 $6.15 Million - $8.82 Million
-98,617 Reduced 10.69%
823,559 $70.7 Million
Q3 2022

Oct 26, 2022
BUY
$59.54 - $68.01 $8.66 Million - $9.9 Million
145,515 Added 18.74%
922,176 $56.9 Million
Q2 2022

Jul 22, 2022
BUY
$57.72 - $65.01 $4.51 Million - $5.08 Million
78,158 Added 11.19%
776,661 $48 Million
Q1 2022

Apr 22, 2022
SELL
$57.92 - $72.58 $1.49 Million - $1.87 Million
-25,743 Reduced 3.55%
698,503 $41.5 Million
Q4 2021

Feb 14, 2022
BUY
$64.88 - $73.64 $196,845 - $223,423
3,034 Added 0.42%
724,246 $52.6 Million
Q3 2021

Nov 05, 2021
SELL
$67.69 - $73.03 $24.1 Million - $26 Million
-355,713 Reduced 33.03%
721,212 $50.4 Million
Q2 2021

Aug 16, 2021
SELL
$63.47 - $69.35 $1.41 Million - $1.54 Million
-22,152 Reduced 2.02%
1,076,925 $74.2 Million
Q1 2021

May 17, 2021
BUY
$60.0 - $68.46 $3.77 Million - $4.3 Million
62,826 Added 6.06%
1,099,077 $71 Million
Q4 2020

Feb 18, 2021
SELL
$56.65 - $64.55 $3.01 Million - $3.43 Million
-53,068 Reduced 4.87%
1,036,251 $60.4 Million
Q3 2020

Nov 05, 2021
BUY
$62.1 - $78.08 $104,514 - $131,408
1,683 Added 0.15%
1,089,319 $68.8 Million
Q3 2020

Nov 13, 2020
BUY
$62.1 - $78.08 $8.39 Million - $10.5 Million
135,025 Added 14.17%
1,087,636 $68.7 Million
Q2 2020

Nov 16, 2021
BUY
$72.34 - $84.0 $126,739 - $147,168
1,752 Added 0.18%
952,611 $73.3 Million
Q2 2020

Aug 14, 2020
SELL
$72.34 - $84.0 $19.9 Million - $23.1 Million
-275,536 Reduced 22.47%
950,859 $73.2 Million
Q1 2020

Nov 05, 2021
BUY
$62.63 - $80.22 $90,187 - $115,516
1,440 Added 0.12%
1,226,395 $91.7 Million
Q1 2020

May 15, 2020
SELL
$62.63 - $80.22 $16.6 Million - $21.2 Million
-264,356 Reduced 17.75%
1,224,955 $91.6 Million
Q4 2019

Nov 16, 2021
BUY
$61.62 - $67.78 $73,512 - $80,861
1,193 Added 0.08%
1,489,311 $96.8 Million
Q4 2019

Feb 14, 2020
BUY
$61.62 - $67.78 $83.6 Million - $91.9 Million
1,356,311 Added 1029.01%
1,488,118 $96.7 Million
Q3 2019

Oct 31, 2019
BUY
$62.51 - $69.0 $551,150 - $608,373
8,817 Added 7.17%
131,807 $8.35 Million
Q2 2019

Jul 24, 2019
SELL
$61.87 - $69.38 $195,756 - $219,518
-3,164 Reduced 2.51%
122,990 $8.31 Million
Q1 2019

Apr 23, 2019
BUY
$62.53 - $70.05 $46,022 - $51,556
736 Added 0.59%
126,154 $8.2 Million
Q4 2018

Jan 22, 2019
SELL
$60.54 - $79.0 $4.97 Million - $6.49 Million
-82,147 Reduced 39.58%
125,418 $7.85 Million
Q3 2018

Oct 17, 2018
SELL
$71.28 - $78.92 $1.09 Million - $1.2 Million
-15,241 Reduced 6.84%
207,565 $16 Million
Q2 2018

Jul 26, 2018
SELL
$64.88 - $75.68 $325,762 - $379,989
-5,021 Reduced 2.2%
222,806 $15.8 Million
Q1 2018

Apr 20, 2018
SELL
$72.84 - $88.8 $570,555 - $695,570
-7,833 Reduced 3.32%
227,827 $17.2 Million
Q4 2017

Jan 29, 2018
SELL
$71.15 - $83.52 $1.39 Million - $1.63 Million
-19,479 Reduced 7.63%
235,660 $16.9 Million
Q3 2017

Oct 23, 2017
BUY
$72.11 - $85.47 $18.4 Million - $21.8 Million
255,139
255,139 $20.7 Million

Others Institutions Holding GILD

# of Institutions
1,931
Shares Held
991M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Truist Financial Corp Portfolio

Follow Truist Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email